Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 02, 2011 | November 04, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 02, 2011 · Filed November 04, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 84,140 |
Reported balance
After 2011-11-02 transaction · row 1
1 source rowRow 1 · 2011-11-02 · Grant · Acquired 3,634 · Balance 84,140 F1: Consists of common stock issued in payment of a semi-annual retainer. |
| Common StockSEC Table I · non-derivative | IndirectBy Membership | 12,153 |
Reported balance
Holding disclosure · report date 2011-11-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,153 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock issued in payment of a semi-annual retainer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2011 Filed Nov 4, 2011 20:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,634 | $35.77 | $129,988.18 |
DisclosureSEC source: 0001127602-11-028666 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,140 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 23, 2011 Filed Oct 7, 2011 20:34 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 75 | $37.91 | $2,843.25 |
DisclosureSEC source: 0001127602-11-027091 · form4a.xml · nonDerivative · entry 5 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,506 F1 · kind: The reporting person has disgorged to the issuer all short swing profits realized on the transactions reported on this Form 4, as amended hereby. The transactions were conducted in discretionary brokerage accounts without the reporting person's knowledge. Read SEC document |
| May 11, 2011 Filed May 13, 2011 19:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,466 | $37.50 | $129,975.00 |
DisclosureSEC source: 0001127602-11-016261 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,386 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| April 29, 2011 Filed May 25, 2011 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCall Option (right to buy) · Derivative | 28 | $2,884.00 Strike: $36.00 | $80,752.00 |
DisclosureSEC source: 0001127602-11-017507 · form4.xml · derivative · entry 5 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 2,800 shares Expires 2011-05-21 Read SEC document |
| April 29, 2011 Filed May 25, 2011 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,800 | $36.23 | $101,450.72 |
DisclosureSEC source: 0001127602-11-017507 · form4.xml · nonDerivative · entry 2 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,920 F1 · price: The reporting person has disgorged to the issuer all short swing profits realized on the reported transactions. The transactions were conducted in a discretionary brokerage account without the reporting person's prior knowledge. Read SEC document |
| March 19, 2011 Filed May 25, 2011 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherCall Options (obligations to sell) · Derivative | 28 | $0.00 Strike: $35.00 | $0.00 |
DisclosureSEC source: 0001127602-11-017507 · form4.xml · derivative · entry 6 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,800 shares Expires 2011-03-19 F2 · kind: Expiration of short call option. Read SEC document |
| March 19, 2011 Filed May 25, 2011 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCall Options (obligations to sell) · Derivative | 28 | $1,540.00 Strike: $36.00 | $43,120.00 |
DisclosureSEC source: 0001127602-11-017507 · form4.xml · derivative · entry 4 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 2,800 shares Expires 2011-05-21 Read SEC document |
| February 22, 2011 Filed Oct 7, 2011 20:34 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 35 | $32.57 | $1,139.95 |
DisclosureSEC source: 0001127602-11-027091 · form4a.xml · nonDerivative · entry 4 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,506 F1 · kind: The reporting person has disgorged to the issuer all short swing profits realized on the transactions reported on this Form 4, as amended hereby. The transactions were conducted in discretionary brokerage accounts without the reporting person's knowledge. Read SEC document |
| February 15, 2011 Filed Oct 7, 2011 20:34 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 35 | $32.86 | $1,150.10 |
DisclosureSEC source: 0001127602-11-027091 · form4a.xml · nonDerivative · entry 3 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,506 F1 · kind: The reporting person has disgorged to the issuer all short swing profits realized on the transactions reported on this Form 4, as amended hereby. The transactions were conducted in discretionary brokerage accounts without the reporting person's knowledge. Read SEC document |
| February 08, 2011 Filed May 25, 2011 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCall Options (obligations to sell) · Derivative | 28 | $840.00 Strike: $35.00 | $23,520.00 |
DisclosureSEC source: 0001127602-11-017507 · form4.xml · derivative · entry 3 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 2,800 shares Expires 2011-03-19 Read SEC document |
| February 08, 2011 Filed May 25, 2011 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 2,800 | $33.28 | $93,172.80 |
DisclosureSEC source: 0001127602-11-017507 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,720 Read SEC document |
| November 04, 2010 Filed Nov 5, 2010 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-027149 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,920 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| June 25, 2010 Filed Oct 7, 2011 20:34 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 45 | $31.75 | $1,428.75 |
DisclosureSEC source: 0001127602-11-027091 · form4a.xml · nonDerivative · entry 2 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,506 F1 · kind: The reporting person has disgorged to the issuer all short swing profits realized on the transactions reported on this Form 4, as amended hereby. The transactions were conducted in discretionary brokerage accounts without the reporting person's knowledge. Read SEC document |
| May 12, 2010 Filed May 14, 2010 20:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-014348 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,477 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| April 26, 2010 Filed Oct 7, 2011 20:34 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 170 | $36.67 | $6,233.90 |
DisclosureSEC source: 0001127602-11-027091 · form4a.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,506 F1 · kind: The reporting person has disgorged to the issuer all short swing profits realized on the transactions reported on this Form 4, as amended hereby. The transactions were conducted in discretionary brokerage accounts without the reporting person's knowledge. Read SEC document |
| November 04, 2009 Filed Nov 6, 2009 21:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,872 | $36.15 | $139,972.80 |
DisclosureSEC source: 0001127602-09-022015 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,623 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| May 06, 2009 Filed May 8, 2009 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,380 | $31.96 | $139,984.80 |
DisclosureSEC source: 0001127602-09-010995 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,751 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| November 05, 2008 Filed Nov 7, 2008 21:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,562 | $30.69 | $140,007.78 |
DisclosureSEC source: 0001127602-08-008962 · form4.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,371 F1 · shares: Consists of common stock acquired as an annual grant, semi-annual compensation and/or meeting fees. Read SEC document |
| May 07, 2008 Filed May 8, 2008 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,370 | $41.53 | $306,076.10 |
DisclosureSEC source: 0000064803-08-000058 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,809 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 15, 2007 Filed Feb 4, 2008 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 25,677 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000012 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,439 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 780 | $41.64 | $32,479.20 |
DisclosureSEC source: 0000064803-07-000169 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,116 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| June 06, 2007 Filed Jun 7, 2007 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionShare Credits · Derivative | 21,690 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000112 · doc.xml · derivative · entry 3 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects issuance of shares in settlement of deferred stock unit account. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| June 06, 2007 Filed Jun 7, 2007 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherCommon Stock | 21,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000112 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,336 F1 · kind: Reflects issuance of shares in settlement of deferred stock unit account. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 09, 2007 Filed May 10, 2007 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,854 | $38.02 | $184,549.08 |
DisclosureSEC source: 0000064803-07-000104 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,646 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 668 | $34.80 | $23,246.40 |
DisclosureSEC source: 0000064803-07-000067 · doc.xml · nonDerivative · entry 2 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Membership Disclosed balance after: 2,148 F2 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark shares owned by the reporting person to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| November 09, 2006 Filed Nov 13, 2006 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,115 | $29.14 | $32,491.10 |
DisclosureSEC source: 0000064803-06-000039 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,792 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 11, 2006 Filed May 15, 2006 23:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,080 | $30.07 | $152,755.60 |
DisclosureSEC source: 0001198219-06-000011 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,677 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 02, 2005 Filed Nov 3, 2005 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,033 | $24.20 | $24,993.44 |
DisclosureSEC source: 0001196361-05-000004 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,597 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| July 06, 2005 Filed Jul 8, 2005 15:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001196361-05-000001 · doc.xml · derivative · entry 4 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cash exercise funded by Insider. Read SEC document |
| July 06, 2005 Filed Jul 8, 2005 15:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 30,000 | $29.64 | $889,050.00 |
DisclosureSEC source: 0001196361-05-000001 · doc.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2005 Filed May 16, 2005 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,464 | $53.83 | $132,624.80 |
DisclosureSEC source: 0001174477-05-000006 · c0001196361d20050516f4f.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,357 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 03, 2004 Filed Nov 5, 2004 17:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001174477-04-000014 · c0001196361d20041105f4s1f.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,893 F1 · kind: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| May 12, 2004 Filed May 14, 2004 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,628 | $39.75 | $104,463.00 |
DisclosureSEC source: 0001174477-04-000007 · c0001196361d20040514f4f.xml · nonDerivative · entry 1 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,329 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1996 Directors Plan. Read SEC document |
| November 05, 2003 Filed Nov 7, 2003 14:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 284 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-03-000038 · c0001196361d20031107f4f.xml · derivative · entry 2 MURRAY TERRENCE · CIK 0001196361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,547 Underlying: Common Stock · 284 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.